ArticleCancer reports (Hoboken, N.J.)2024

SMAD4 inhibits glycolysis in ovarian cancer through PI3K/AKT/HK2 signaling pathway by activating ARHGAP10.

Kui Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.